These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7009393)

  • 1. Proflavine, proflavine dihydrochloride, proflavine hemisulphate and proflavine monohydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():195-209. PubMed ID: 7009393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carcinogenic and mutagenic activities of 3,3'-dichlorobenzidine derivatives--yellow transparent O and K pigments].
    Pylev LN; Vasil'eva LA; Soldatova NG; Gurski T; Galkevich E
    Gig Tr Prof Zabol; 1985 Nov; (11):34-9. PubMed ID: 4085891
    [No Abstract]   [Full Text] [Related]  

  • 3. Photocarcinogenesis by methoxypsoralen, neutral red and proflavine.
    Santamaria L; Arnaboldi A; Daffara P; Bianchi A
    Boll Chim Farm; 1979 Jul; 118(7):356-62. PubMed ID: 526353
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenelzine and phenelzine sulphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():175-84. PubMed ID: 7009391
    [No Abstract]   [Full Text] [Related]  

  • 5. Nafenopin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():125-33. PubMed ID: 7009388
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():59-76. PubMed ID: 7009401
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():243-58. PubMed ID: 7009395
    [No Abstract]   [Full Text] [Related]  

  • 8. Occupational dermatitis from proflavine.
    Goh CL
    Contact Dermatitis; 1987 Oct; 17(4):256. PubMed ID: 2962831
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenoxybenzamine and phenoxybenzamine hydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():185-94. PubMed ID: 7009392
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenacetin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():135-61. PubMed ID: 7009389
    [No Abstract]   [Full Text] [Related]  

  • 11. Benz[c]acridine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():129-34. PubMed ID: 6586642
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema multiforme-like and purpuric eruption due to contact allergy to proflavine.
    Goh CL
    Contact Dermatitis; 1987 Jul; 17(1):53-4. PubMed ID: 3652692
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofibrate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():39-58. PubMed ID: 7009400
    [No Abstract]   [Full Text] [Related]  

  • 14. Contact sensitivity to proflavine.
    Goh CL
    Int J Dermatol; 1986 Sep; 25(7):449-51. PubMed ID: 3771042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():165-202. PubMed ID: 6944258
    [No Abstract]   [Full Text] [Related]  

  • 16. Methoxsalen.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():101-24. PubMed ID: 6937435
    [No Abstract]   [Full Text] [Related]  

  • 17. Dibenz[a,j]acridine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():283-8. PubMed ID: 6586659
    [No Abstract]   [Full Text] [Related]  

  • 18. Dibenz[a,h]acridine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():277-81. PubMed ID: 6586658
    [No Abstract]   [Full Text] [Related]  

  • 19. Prednisone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():293-309. PubMed ID: 6944264
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of formulation on the percutaneous absorption of proflavine hemisulphate.
    Selkirk AB; Dolder R
    Pharm Acta Helv; 1976; 51(6):160-3. PubMed ID: 959240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.